Mycophenolate Tablets Delayed Release and Orthoclone OKT 3
Determining the interaction of Mycophenolate Tablets Delayed Release and Orthoclone OKT 3 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mycophenolic acid
Brand name: Myfortic
Synonyms: Mycophenolic acid
Generic Name: muromonab-cd3
Brand name:
Synonyms: Orthoclone OKT 3 (Intravenous), Orthoclone OKT3
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mycophenolate Tablets Delayed Release-Orthovisc
- Mycophenolate Tablets Delayed Release-Orudis
- Mycophenolate Tablets Delayed Release-Orudis KT
- Mycophenolate Tablets Delayed Release-Oruvail
- Mycophenolate Tablets Delayed Release-Orvaten
- Mycophenolate Tablets Delayed Release-Os-Cal 500+D
- Orthoclone OKT 3-Mycophenolic acid
- Orthoclone OKT 3-Mycophenolic Acid Delayed-Release Tablets
- Orthoclone OKT 3-Mycophenolic Acid Tablets
- Orthoclone OKT 3-Mycostatin (Nystatin Oral Suspension)
- Orthoclone OKT 3-Mycostatin (Nystatin Tablets and Capsules)
- Orthoclone OKT 3-Mycostatin Suspension